Pfizer and GSK to battle for share of new RSV vaccine market
With both GSK and Pfizer recently gaining FDA approval for their respective respiratory syncytial virus (RSV) vaccines, the stakes are high for competition in the sector.
Archives for June 13, 2023
Rosa Biotech accelerates NASH pre-clinical trial in liver disease
Following its latest funding round, Rosa Biotech has announced plans to accelerate development of its bio-sensing technology, designed to enable cost effective screening of a range of diseases with high accuracy at an early stage.
Sygnature Discovery launches in vivo inflammation model and includes kidney and neuroinflammation
Sygnature Discovery has launched an in vivo inflammation model, that the company says is ‘exciting but only the beginning’ of understanding life-limiting neuroinflammatory conditions.